000 01241 a2200349 4500
005 20250511200455.0
264 0 _c19910830
008 199108s 0 0 eng d
022 _a0278-5846
024 7 _a10.1016/0278-5846(91)90065-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBartko, G
245 0 0 _aEffects of adjunctive verapamil administration in chronic schizophrenic patients.
_h[electronic resource]
260 _bProgress in neuro-psychopharmacology & biological psychiatry
_c1991
300 _a343-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAntipsychotic Agents
_xtherapeutic use
650 0 4 _aDyskinesia, Drug-Induced
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPsychiatric Status Rating Scales
650 0 4 _aSchizophrenia
_xcomplications
650 0 4 _aSchizophrenic Psychology
650 0 4 _aVerapamil
_xtherapeutic use
700 1 _aHorvath, S
700 1 _aZador, G
700 1 _aFrecska, E
773 0 _tProgress in neuro-psychopharmacology & biological psychiatry
_gvol. 15
_gno. 3
_gp. 343-9
856 4 0 _uhttps://doi.org/10.1016/0278-5846(91)90065-9
_zAvailable from publisher's website
999 _c1684189
_d1684189